{'fraction_non_alphanumeric': 0.028455284552845527, 'fraction_numerical': 0.006968641114982578, 'mean_word_length': 6.726457399103139, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Pseudocatalytic Hydrogels with Intrinsic Antibacterial and Photothermal Activities for Local Treatment of Subcutaneous Abscesses and Breast Tumors

The intimate relationship between bacteria and tumors has triggered a lot of activities in the development and design of bioactive materials to concurrently respond to antitumor and antibacterial demands. Herein, a pseudocatalytic hydrogel (AM‐I@Agar) with intrinsic antibacterial and photothermal activities, synthesized by incorporating prefabricated amylose‐iodine nanoparticles into low‐melting‐point agarose hydrogel, is explored as a bioactive agent for local treatment of subcutaneous abscesses and breast tumors. The AM‐I@Agar hydrogel depicts the ability of pseudocatalytic O2 generation from H2O2 to alleviate hypoxia. Meanwhile, the AM‐I@Agar hydrogel exhibits temperature self‐regulation features, beneficial for avoiding thermal injury during photothermal therapy owing to thermochromic properties. Upon local injection into a subcutaneous abscess, methicillin‐resistant Staphylococcus aureus is effectively eliminated by the AM‐I@Agar hydrogel, and complete skin recovery is achieved in 8 d, demonstrating much better antibacterial effects compared with penicillin, a small‐molecule antibiotic. AM‐I/5‐FU@Agar hydrogel, obtained after loading 5‐fluorouracil (5‐FU), significantly inhibits tumors in both normal 4T1 tumor‐bearing mice and MRSA‐infected 4T1 tumor‐bearing mice models via a synergistic photothermal‐chemo effect, and shows treatment efficiency superior to that achieved with photothermal therapy or 5‐FU alone. This work provides a concept for the design and development of bioactive agents for potential management of bacteria‐associated cancer.